KaydedilenlerDerginizi ekleyin

Dergiler / E Journal of Cardiovascular Medicine / 2018 / Cilt: 6 - Sayı: 4

Comparison of Mortality and Morbidity in Syrian and Turkish Premature Babies with Patent Ductus Arteriosus

Birol KARABULUT
Ayşe ŞİMŞEK
Sayfa
134–139
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The higher morbidity and mortality rate of PDA in our Syrian patients may be related to the low socioeconomic level resulting from the war in Syria or the difference in the genetic structure.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background: Having observed that the clinical course of premature infants at the 28th gestational week and earlier followed-up in our department was different between races, we aimed to examine the effect of the genetic structure on patent ductus arteriosus (PDA) regarding morbidity and mortality among Turkish and Syrian babies.
📊
Temel Bulgular & Veri:Methods: This single-center, retrospective study was carried out with 43 Turkish newborns (group 1) and 31 Syrian newborns (group 2) with a gestational age of 28 weeks or less who had been followed-up between February 2016 and March 2018 in our department after exclusion of the risk factors that may affect ductus arteriosus, and compared the morbidity and mortality of the study groups.
💡
Sonuç & Katkı:Conclusion: The higher morbidity and mortality rate of PDA in our Syrian patients may be related to the low socioeconomic level resulting from the war in Syria or the difference in the genetic structure.
🔬Tür:Araştırma Makalesi
📍Kapsam:2016 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Background: Having observed that the clinical course of premature infants at the 28th gestational week and earlier followed-up in our department was different between races, we aimed to examine the effect of the genetic structure on patent ductus arteriosus (PDA) regarding morbidity and mortality among Turkish and Syrian babies. Methods: This single-center, retrospective study was carried out with 43 Turkish newborns (group 1) and 31 Syrian newborns (group 2) with a gestational age of 28 weeks or less who had been followed-up between February 2016 and March 2018 in our department after exclusion of the risk factors that may affect ductus arteriosus, and compared the morbidity and mortality of the study groups. Results: The diameter of the duct, the left atrium/aortic root ratio, the need for ductus occluding intervention, bronchopulmonary dysplasia, hospital stay and mortality rate were significantly higher in Syrian newborns (group 2). Conclusion: The higher morbidity and mortality rate of PDA in our Syrian patients may be related to the low socioeconomic level resulting from the war in Syria or the difference in the genetic structure.

🔖

Bu Makaleye Atıf Yap

KARABULUT, B., ŞİMŞEK, A. (2018). Comparison of Mortality and Morbidity in Syrian and Turkish Premature Babies with Patent Ductus Arteriosus. E Journal of Cardiovascular Medicine, Cilt: 6 - Sayı: 4, 134–139. https://ajindex.com/articles/154329

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Weinberg JG, Evans FJ, Burns KM, Pearson GD, Kaltman JR. Surgical ligation of patent ductus arteriosus in premature infants: trends and practice variation. Cardiol Young 2015;26:1107-14.
  2. Mirea L, Sankaran K, Seshia M, et al. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: Adjustment for treatment selection bias. J Pediatr 2012;161:689-94.
  3. Sehgal A, McNamara PJ. The ductus arteriosus: A refined approach. Semin Perinatol 2012;36:105-13.
  4. Clyman RI, Ballard PL, Sniderman S, et al. Prenatal administration of betamethasone for prevention of patient ductus arteriosus. J Pediatr 1981;98:123-6.
  5. Park HW, Choi YS, Kim KS, Kim SN. Chorioamnionitis and patent ductus arteriosus: A systematic review and meta-analysis. PLoS One 2015;16;10:e0138114. Kim ES, Kim EK, Choi CW, et al. Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants. J Pediatr 2010;157:745-50.
  6. Rakza T, Magnenant E, Klosowski S, Tourneux P, Bachiri A, Storme L. Early hemodynamic consequences of patent ductus arteriosus in preterm infants with intrauterine growth restriction. J Pediatr 2007;151:424-8.
  7. Shelton EL, Ector G, Galindo CL, et al. Transcriptional profiling reveals ductus arteriosus specific genes that regulate vascular tone. Physiol Genomics 2014;46:457-66.
  8. Bhandari V, Zhou G, Bizzarro MJ, et al. Genetic contribution to patent ductus arteriosus in the premature newborn. Pediatrics 2009;123:669-73.
  9. Reese J, Veldman A, Shah L, Vucovich M, Cotton RB. Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period. Semin Perinatol 2010;34:222-30.
  10. Capozzi G, Santoro G. Patent ductus arteriosus: patho-physiology, hemodynamic effects and clinical complications. J Matern Fetal Neonatal Med 2011;24(Suppl 1):15-6. Turkish Neonatology Association’s Approach to Patent ductus arteriosus in a premature baby 2016.
  11. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33:179-201.
  12. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500gm. J Pediatr 1978;92:529-34. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005;123:991-9.
  13. Schena F, Francesca